文献速递湿疹皮炎与荨麻疹皮肤肿瘤

紫外线B光疗不增加特应性皮炎患者皮肤癌风险

Ultraviolet B phototherapy does not increase the risk of skin cancer among patients with atopic dermatitis: A population-based retrospective cohort study.
PubMed 文献 · J Am Acad Dermatol · 2023-05-24

该研究基于2001至2018年全国性人群队列,纳入6205例特应性皮炎患者,比较接受与未接受紫外线B光疗者的皮肤癌风险。结果显示,光疗组皮肤癌、非黑色素瘤皮肤癌和皮肤黑色素瘤的风险均未增加,且光疗次数与皮肤癌风险无关。

要点

  • 紫外线B光疗未增加特应性皮炎患者皮肤癌风险(调整HR 0.91,95%CI 0.35-2.35)。
  • 非黑色素瘤皮肤癌和皮肤黑色素瘤风险亦未增加,调整HR分别为0.80和0.80。
  • 紫外线B光疗次数与皮肤癌风险无关(调整HR 0.99,95%CI 0.96-1.02)。

核心结论

  • 紫外线B光疗及光疗次数均与特应性皮炎患者皮肤癌风险增加无关。

研究设计与样本

  • 研究为2001至2018年全国性人群回顾性队列研究,纳入6205例特应性皮炎患者。

主要发现

  • 接受紫外线B光疗的特应性皮炎患者皮肤癌风险未增加(调整HR 0.91,95%CI 0.35-2.35)。
  • 非黑色素瘤皮肤癌风险未增加(调整HR 0.80,95%CI 0.29-2.26)。
  • 皮肤黑色素瘤风险未增加(调整HR 0.80,95%CI 0.08-7.64)。
  • 紫外线B光疗次数与皮肤癌风险无关(调整HR 0.99,95%CI 0.96-1.02)。
  • 紫外线B光疗次数与非黑色素瘤皮肤癌风险无关(调整HR 0.99,95%CI 0.96-1.03)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 回顾性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: UV-B phototherapy is a common treatment modality for patients with atopic dermatitis (AD), but its long-term safety in terms of cutaneous carcinogenic risk has not been studied. OBJECTIVE: To investigate the risk of skin cancer among patients with AD receiving UV-B phototherapy. METHODS: We conducted a nationwide population-based cohort study from 2001 to 2018 to estimate the risk of UV-B phototherapy for skin cancer, nonmelanoma skin cancer, and cutaneous melanoma in patients with AD. RESULTS: Among 6205 patients with AD, the risks of skin cancer (adjusted hazard ratio [HR], 0.91; 95% CI, 0.35-2.35), nonmelanoma skin cancer (adjusted HR, 0.80; 95% CI, 0.29-2.26), and cutaneous melanoma (adjusted HR, 0.80; 95% CI, 0.08-7.64) did not increase among patients with AD treated with UV-B phototherapy, compared with those who did not receive UV-B phototherapy. Additionally, the number of UV-B phototherapy sessions was not associated with an increased risk of skin cancer (adjusted HR, 0.99; 95% CI, 0.96-1.02), nonmelanoma skin cancer (adjusted HR, 0.99; 95% CI, 0.96-1.03), or cutaneous melanoma (adjusted HR, 0.94; 95% CI, 0.77-1.15). LIMITATIONS: Retrospective study. CONCLUSION: Neither UV-B phototherapy nor the number of UV-B phototherapy sessions was associated with an increased risk of skin cancers among patients with AD.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Ko MJ, Tsai WC, Tsai PH, et al. Ultraviolet B phototherapy does not increase the risk of skin cancer among patients with atopic dermatitis: A population-based retrospective cohort study. J Am Acad Dermatol. 2023. PMID: 37236426. doi:10.1016/j.jaad.2023.05.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。